Psychedelics
MindMed sets milestone in finding psychedelic cure for opioid addiction
The company has come up with a derivative of ibogaine, a psychoactive substance from an African shrub.
PharmaTher advances in work to develop microneedle patch for psychedelics
Toronto company seeks to come up with alternative way to administer psychedelic substances.
Optimi Health completes development of mushroom facility in B.C.
The Vancouver functional and psychedelic fungi company has applied for a Health Canada dealer’s licence.
Canadian government supports MYND Life Sciences research on psilocybin
The National Research Council of Canada Industrial Research Assistance Program is providing advisory services and funding.
Vancouver cannabis processor Nextleaf applies for psychedelics licence
The Vancouver-based company wants to engage in range of activities related to psilocybin and psilocin.
How does microdosing with LSD affect sleep? MindMed study seeks answers
The New York-based psychedelic company announces recruitment for research.